Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists

Journal of Neuroscience

Volumn 17, Issue 10, 1997, Pages 3840-3846

  Emmi, Adriana ^a   Rajabi, Heshmat ^a   Stewart, Jane ^a  

^a and Applied Physiology   (Canada)

Author keywords

6 OHDA lesions; behavioral recovery; D1 D5 receptor antagonists; D2 receptor antagonists; microdialysis; striatal dopamine; substantia nigra

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 5 RECEPTOR; ECOPIPAM; ETICLOPRIDE; OXIDOPAMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUBSTANTIA NIGRA;

EID: 0030907042     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-10-03840.1997     Document Type: Article

References (21)

1. Abercrombie ED, Bonatz AE, Zigmond MJ (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res 525:36-44.
2. Akimoto K, Hamamura T, Kazahaya Y, Akiyama K, Otsuki S (1990) Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensntization betweeen methamphetamine and cocaine: an in vivo dialysis study in freely moving rats. Brain Res 507:344-346.
3. Altar CA, Hanser K (1987) Topography of substantia nigra innervation by D1 receptor-containing striatal neurons. Brain Res 410:1-11.
4. Bjijou Y, Stinus L, Le Moal M, Cador M (1996) Evidence for a selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther 277:1177-1187.
5. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395.
6. Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344-347.
7. Castañeda E, Whishaw IQ, Robinson TE (1990) Changes in striatal dopamine neurotransmission assessed with microdialysis following recovery from a bilateral 6-OHDA lesion: variation as a function of lesion size. J Neurosci 10:1847-1854.
8. Chen Z, Fujii S, Ito K-I, Kato H, Kaneko K, Miyakawa H (1995) Activation of dopamine D1 receptors enhances long-term depression of synaptic transmission induced by low frequency stimulation in rat hippocampus CA1 neurons. Neurosci Lett 188:195-198.
9. Criswell H, Mueller RA, Breese GR (1989) Priming of D1-dopamine receptor responses: long-lasting behavioral supersensitivity to a D1-dopamine agonist following repeated administration to neonatal 6-OHDA-lesions rats. J Neurosci 9:125-133.
10. 1-dopamine receptor sensitization in neonatal 6-OHDA-lesioned rats is blocked by an NMDA antagonist. Brain Res 512:284-290.
11. Dewar K, Rompré P-P, Stewart J, Warren RA (1996) Excitotoxic lesions of the medial prefrontal cortex reduce dopamine D1-like binding sites in the ventral tegmental area. Abstr Soc Neurosci 22:828.
12. Drew KL, Glick SD (1990) Role of D1 and D2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response. Psychopharmacology 101:465-471.
13. Emmi A, Rajabi H, Stewart J (1996) Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists, MK-801 and CPP. J Neurosci 16:5216-5224.
14. Floran B, Aceves J, Sierra A, Martinez-Fong D (1990) Activation of D1 dopamine receptors stimulates the release of GABA in the basal ganglia of the rat. Neurosci Lett 116:136-140.
15. Henry DJ, White FJ (1991) Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
16. Hoffman DC, Donovan H (1994) D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia. Psychopharmacology 115:447-453.
17. Huang Y-Y, Kandel ER (1995) D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. Proc Natl Acad Sci USA 92:2446-2450.
18. Jeziorski M, White FJ (1995) Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization. Eur J Pharmacol 275:235-244.
19. Kalivas PW, Duffy P (1995) D1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
20. Kalivas PW (1995) Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37:95-100.
21. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci 13:266-275.